GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » PE Ratio (TTM)

China National Accord Medicines (SZSE:000028) PE Ratio (TTM) : 11.62 (As of Jun. 23, 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines PE Ratio (TTM)?

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). As of today (2024-06-23), China National Accord Medicines's share price is ¥33.92. China National Accord Medicines's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.92. Therefore, China National Accord Medicines's PE Ratio (TTM) for today is 11.62.


The historical rank and industry rank for China National Accord Medicines's PE Ratio (TTM) or its related term are showing as below:

SZSE:000028' s PE Ratio (TTM) Range Over the Past 10 Years
Min: 9.55   Med: 17.04   Max: 49.03
Current: 11.62


During the past 13 years, the highest PE Ratio (TTM) of China National Accord Medicines was 49.03. The lowest was 9.55. And the median was 17.04.


SZSE:000028's PE Ratio (TTM) is ranked better than
73.68% of 76 companies
in the Medical Distribution industry
Industry Median: 18.285 vs SZSE:000028: 11.62

China National Accord Medicines's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was ¥0.70. Its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.92.

As of today (2024-06-23), China National Accord Medicines's share price is ¥33.92. China National Accord Medicines's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.09. Therefore, China National Accord Medicines's PE Ratio without NRI for today is 10.97.

During the past 13 years, China National Accord Medicines's highest PE Ratio without NRI was 45.97. The lowest was 7.85. And the median was 16.44.

China National Accord Medicines's EPS without NRI for the three months ended in Mar. 2024 was ¥0.77. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.09.

During the past 12 months, China National Accord Medicines's average EPS without NRI Growth Rate was -3.20% per year. During the past 3 years, the average EPS without NRI Growth Rate was 1.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was 3.40% per year. During the past 10 years, the average EPS without NRI Growth Rate was 8.20% per year.

During the past 13 years, China National Accord Medicines's highest 3-Year average EPS without NRI Growth Rate was 94.10% per year. The lowest was -38.20% per year. And the median was 15.25% per year.

China National Accord Medicines's EPS (Basic) for the three months ended in Mar. 2024 was ¥0.70. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.92.


China National Accord Medicines PE Ratio (TTM) Historical Data

The historical data trend for China National Accord Medicines's PE Ratio (TTM) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines PE Ratio (TTM) Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio (TTM)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.32 14.01 11.85 9.48 10.10

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PE Ratio (TTM) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.84 14.78 10.80 10.10 10.52

Competitive Comparison of China National Accord Medicines's PE Ratio (TTM)

For the Medical Distribution subindustry, China National Accord Medicines's PE Ratio (TTM), along with its competitors' market caps and PE Ratio (TTM) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's PE Ratio (TTM) Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's PE Ratio (TTM) distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's PE Ratio (TTM) falls into.



China National Accord Medicines PE Ratio (TTM) Calculation

The PE Ratio (TTM), or Price-to-Earnings ratio, or P/E Ratio, is a financial ratio used to compare a company's market price to its Earnings per Share (Diluted). It is the most widely used ratio in the valuation of stocks.

China National Accord Medicines's PE Ratio (TTM) for today is calculated as

PE Ratio (TTM)=Share Price/Earnings per Share (Diluted) (TTM)
=33.92/2.920
=11.62

China National Accord Medicines's Share Price of today is ¥33.92.
China National Accord Medicines's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2.92.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PE Ratio (TTM)=Market Cap /Net Income

There are at least three kinds of PE Ratio (TTM)s used by different investors. They are Trailing Twelve Month PE Ratio (TTM) or PE Ratio (TTM) (TTM), Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio (TTM) based on inflation-adjusted normalized PE Ratio (TTM) is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the calculation of PE Ratio (TTM), the earnings per share used are the earnings per share over the past 12 months. For Forward PE Ratio, the earnings are the expected earnings for the next twelve months. In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


China National Accord Medicines  (SZSE:000028) PE Ratio (TTM) Explanation

The PE Ratio (TTM) can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio (TTM) is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio (TTM) is positive. Also for stocks with the same PE Ratio (TTM), the one with faster growth business is more attractive.

If a company loses money, the PE Ratio (TTM) becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio (TTM) divided by the growth ratio. He thinks a company with a PE Ratio (TTM) equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio (TTM) of 20, instead of a company growing 10% a year with a PE Ratio (TTM) of 10.

Because the PE Ratio (TTM) measures how long it takes to earn back the price you pay, the PE Ratio (TTM) can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio without NRI or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio (TTM) measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio (TTM) can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio (TTM)s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio (TTM) is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio .

PE Ratio (TTM) can also be affected by non-recurring-items such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio (TTM).


China National Accord Medicines PE Ratio (TTM) Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's PE Ratio (TTM) provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines